Skip to main content
Premium Trial:

Request an Annual Quote

Paired Ends: Jan 13, 2009


Michael Kochersperger has become vice president of engineering at BioNanomatrix.

He will focus on the commercial design and development of BioNanomatrix's whole genome imaging and analysis system.

Previously, Kochersperger was vice president of engineering at New Brunswick Scientific, a division of Eppendorf. Prior to that, he was director of SNP-IT genotyping research and development at Orchid Biosciences, and before that, project manager for the development of a combinatorial chemistry synthesis system at Applera. Kochersperger holds a BS in chemical engineering from Ohio State University.

Kimberly Popovits has been promoted to president and CEO at Genomic Health, from president and chief operating officer. She replaces Randy Scott, who is now full-time executive chairman of the company. Bradley Cole is replacing Popovits as chief operating officer and will continue to be the company's chief financial officer.

Prior to joining Genomic Health in 2002, Popovits held various roles at Genentech, including senior vice president for marketing and sales. She holds a BA in business from Michigan State University.

Cole, before he joined Genomic Health in 2004, held various senior management positions at Guidant and Applied Biosystems. Cole holds an MBA from San Jose State University and a BS in business from Biola University.